Results 41 to 50 of about 2,600 (141)

Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study

Cancer, Volume 130, Issue 16, Page 2812-2821, 15 August 2024.
Abstract Introduction Nirogacestat is a targeted gamma secretase inhibitor approved in the United States for adults with progressing desmoid tumors. In the phase 3 DeFi study (NCT03785964) of nirogacestat, ovarian toxicity (OT) was identified as a safety signal among females of reproductive potential (FORP).
Elizabeth T. Loggers, Rashmi Chugh, Noah Federman, Lee Hartner, Richard F. Riedel, Sunny Cho, David Hyslop, Allison Lim, Ana B. Oton, Kutluk H. Oktay   +9 more
wiley   +1 more source

Adatbázis-ajánló, Szolgáltatási lehetőségek a MEDINFO adatbázisaiból

, 2018
This review presents uses of the forty databases available from MEDINFO directly and through MEDINFO as gateway, with special focus on International Digest of Health Legislation, WHO, KABIT and ADONIS databases.Az 1989-90-ben elindult társadalmi ...
Jehoda, Imola, Latin, Györgyi, Percze, Lajosné   +2 more
core   +1 more source

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology, Volume 99, Issue 5, Page 880-889, May 2024.
Abstract Axicabtagene ciloleucel (axi‐cel) in trials has demonstrated favorable efficacy compared with historical controls after ≥2 lines of therapy for the treatment of relapsed or refractory (R/R) large B cell lymphoma (LBCL). Herein, we compared the real‐world effectiveness of axi‐cel with efficacy and effectiveness of chemoimmunotherapy (CIT) in ...
Matthew A. Lunning, Hai‐lin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Sairah Ahmed, David B. Miklos, Yi Lin, Brian T. Hill, Armin Ghobadi, Sattva S. Neelapu, Jason Westin, Christopher Dieyi, Polly Field, Harry Miao, Shilpa A. Shahani, Anik Patel, Clare Spooner, Christine Fu, David Muramoto, Hairong Xu, Marcelo C. Pasquini   +22 more
wiley   +1 more source

Youth Med.Info: a case study in co-design of mental health medicines-information resources for children, young people and their parents/guardians

BMJ Open
Objectives To address the lack of accurate and accessible mental health medicines-information resources for children, young people and their parents/guardians using design thinking to co-design free-to-use, video resources tailored to this audience ...
Aoife Carolan, Dolores Keating, Judith Strawbridge, Stephen McWilliams, Maria Migone, Caroline Hynes-Ryan, Ian Kelleher, Sophie Kathryn, Charlie Beaudelot, David Columb, Sarah Donnelly, Nimantha Gamage, Nessa Hill, Joseph Morning, Brian O’Donoghue, Izzie Solan, John Christopher Hayden   +16 more
doaj   +1 more source

Nature‐versus‐nurture considered harmful: Actionability as an alternative tool for understanding the exposome from an ethical perspective

Bioethics, Volume 38, Issue 4, Page 356-366, May 2024.
Abstract Exposome research is put forward as a major tool for solving the nature‐versus‐nurture debate because the exposome is said to represent “the nature of nurture.” Against this influential idea, we argue that the adoption of the nature‐versus‐nurture debate into the exposome research program is a mistake that needs to be undone to allow for a ...
Caspar W. Safarlou, Annelien L. Bredenoord, Roel Vermeulen, Karin R. Jongsma   +3 more
wiley   +1 more source

medinfo ist umgezogen

, 2006
medinfo liegt jetzt auch auf dem Server der UB Dortmund. Dank des unermüdlichen Einsatzes von Olli hat die Umleitung geklappt und medinfo ist seit gestern weiter unter der alten Adresse http://medinfo.netbib.de zu ...
Edlef Stabenau
core  

Long‐term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trial

Muscle &Nerve, Volume 69, Issue 1, Page 93-98, January 2024.
Abstract Introduction/Aims Delandistrogene moxeparvovec is indicated in the United States for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene. Long‐term delandistrogene moxeparvovec microdystrophin protein (a shortened dystrophin that retains key ...
Jerry R. Mendell, Zarife Sahenk, Kelly J. Lehman, Linda P. Lowes, Natalie F. Reash, Megan A. Iammarino, Lindsay N. Alfano, Sarah Lewis, Kathleen Church, Richard Shell, Rachael A. Potter, Danielle A. Griffin, Mark Hogan, Shufang Wang, Stefanie Mason, Eddie Darton, Louise R. Rodino‐Klapac   +16 more
wiley   +1 more source

Wie wird GMS Medizin – Bibliothek – Information genutzt? Analyse der Zugriffszahlen einer Open Access-Zeitschrift / Usage of "GMS Medizin – Bibliothek – Information": analysis of usage data from an Open Access journal

GMS Medizin – Bibliothek – Information, 2008
In 2006 the journal "MEDIZIN – BIBLIOTHEK – INFORMATION" changed from the internet platform of the "Arbeitsgemeinschaft für Medizinisches Bibliothekswesen" (AGMB) to the Open Access platform German Medical Science (GMS).
Bauer, Bruno
doaj  

Skim through medinfo: Information from the medinfo weblog (May-December 2008)

, 2008
Are you up to date? This article provides a selection of the most interesting contents of the weblog medinfo from May to December 2008.Sind Sie auf dem Laufenden?
Klein, D
core  

Skim through medinfo: Information from the medinfo weblog (September-December 2007)

, 2007
Are you up to date? This article provides a selection of the most interesting contents of the weblog medinfo from September to December 2007.Sind Sie auf dem Laufenden? Dieser Beitrag enthält eine Auswahl der interessantesten Inhalte aus dem medinfo-Blog
Klein, D
core